Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma

Molecular Case Studies(2020)10.1101/mcs.a005439Source: DataRank Database

Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma is a research paper published in Molecular Case Studies (2020). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

reactome refsnp doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: goldTopics (53)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Danielle McClanahan ORCID,James E. Jacobs,Sophia Jeng,Myles Vigoda ORCID,Aurora Blucher ORCID

Live enrichment

PubMed:32843430 PMC:PMC7476409 OpenAlex:https://openalex.org/W3080673177

NCI NIH HHS

Grant: T32 CA106195

NCI NIH HHS

Grant: P30 CA069533

NCI NIH HHS

Grant: U54 CA224019

NCI NIH HHS

Grant: R01 CA192405

NCI NIH HHS

Grant: R01 CA108947

NCI NIH HHS

Grant: U01 CA217862

National Institutes of Health

Grant: 5R01CA192405-04

Illuminating molecular targetable pathways in HNSCC

National Institutes of Health

Grant: 5U54CA224019-03

Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML

National Institutes of Health

Grant: 3P30CA069533-21S3

OHSU Knight Cancer Institute

National Institutes of Health

Grant: 5U01CA217862-03

Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies

goldLicense: cc-by-nc

journalhttp://molecularcasestudies.cshlp.org/content/6/4/a005439.full.pdf

publisherhttp://molecularcasestudies.cshlp.org/content/6/4/a005439.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/mcs.a005439

journalhttps://doi.org/10.1101/mcs.a005439

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32843430

Fields of Study

Nonmelanoma Skin Cancer StudiesImmunotherapy and Immune ResponsesInfectious Diseases and Mycology0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Exome SequencingAgedAged, 80 and overCarcinoma, Squamous CellCell SurvivalHumansMaleMiddle AgedMutationSkin NeoplasmsSignal TransductionGene ExpressionGene Expression Regulation, NeoplasticDisease ProgressionGenomicsReceptor, EphA6Receptor, EphA7Small Molecule Libraries

Keywords

MedicineCancer researchErythropoietin-producing hepatocellular (Eph) receptorEphrinOncologyBioinformaticsBiologyInternal medicineReceptorSquamous Cell Carcinoma Of The SkinResearch ReportAged, 80 and overMaleSkin NeoplasmsCell SurvivalGene ExpressionReceptor, EphA6GenomicsReceptor, EphA7Middle AgedGene Expression Regulation, NeoplasticSmall Molecule LibrariesMutationExome SequencingCarcinoma, Squamous CellDisease ProgressionHumansAgedSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being